Sokleaph Cheng

Sokleaph Cheng

Auto-generated profile, based on publicly available information

Sokleaph Cheng

Medical Biology Laboratory, Institut Pasteur du Cambodge, Phnom Penh, Cambodia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2016 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
OMOlivier Marcy
Olivier Marcy
VUVibol Ung
Vibol Ung
SGSophie Goyet
Sophie Goyet
LBLaurence Borand
Laurence Borand
PMPhilippe Msellati
Philippe Msellati
CDChristophe Delacourt
Christophe Delacourt
Background. The diagnosis of tuberculosis in human immunodeficiency virus (HIV)-infected children is challenging. We assessed the performance of alternative specimen collection methods for tuberculosis diagnosis in HIV-infected children using Xpert MTB/RIF (Xpert). Methods. HIV-infected children aged ≤13 years with suspected intrathoracic tuberculosis were enrolled in 8 hospitals in Burkina Faso, Cambodia, Cameroon, and Vietnam. Gastric aspirates were taken for children aged <10 years and expectorated sputum samples were taken for children aged ≥10 years (standard samples); nasopharyngeal aspirate and stool were taken for all children, and a string test was performed if the child was aged ≥4 years (alternative samples). All samples were tested with Xpert. The diagnostic accuracy of Xpert for culture-confirmed tuberculosis was analyzed in intention-to-diagnose and per-protocol approaches. Results. Of 281 children enrolled, 272 (96.8%) had ≥1 specimen tested with Xpert (intention-to-diagnose population), and 179 (63.5%) had all samples tested with Xpert (per-protocol population). Tuberculosis was culture-confirmed in 29/272 (10.7%) children. Intention-to-diagnose sensitivities of Xpert performed on all, standard, and alternative samples were 79.3% (95% confidence interval [CI], 60.3-92.0), 72.4% (95% CI, 52.8-87.3), and 75.9% (95% CI, 56.5-89.7), respectively. Specificities were ≥97.5%. Xpert combined on nasopharyngeal aspirate and stool had intention-to-diagnose and per-protocol sensitivities of 75.9% (95% CI, 56.5-89.7) and 75.0% (95% CI, 47.6-92.7), respectively. Conclusions. The combination of nasopharyngeal aspirate and stool sample is a promising alternative to methods usually recommended by national programs. Xpert performed on respiratory and stools samples enables rapid confirmation of tuberculosis diagnosis in HIV-infected children. Clinical Trials Registration. The ANRS (Agence Nationale de Recherche sur le Sida) 12229 PAANTHER (Pediatric Asian African Network for Tuberculosis and HIV Research) 01 study is registered at ClinicalTrials.gov (NCT01331811).

1 February 2018 in The Lancet HIV
Verified
Journal Article
Closed access
OMOlivier Marcy
Olivier Marcy
MTMathurin Cyrille Tejiokem
Mathurin Cyrille Tejiokem
PMPhilippe Msellati
Philippe Msellati
KHKhanh Truong Huu
Khanh Truong Huu
VCViet Do Chau
Viet Do Chau
IFIsabelle Fournier-Nicolle
Isabelle Fournier-Nicolle

14 July 2024 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
MHMallorie Hide
Mallorie Hide
SMSoda Meng
Soda Meng
SCSokleaph Cheng
Sokleaph Cheng
ABAnne-Laure Banuls
Anne-Laure Banuls
SKSanty Ky
Santy Ky
GDGauthier DELVALLEZ
Gauthier DELVALLEZ
. Despite the critical importance of colistin as a last-resort antibiotic, limited studies have investigated colistin resistance in human infections in Cambodia. This study aimed to investigate the colistin resistance and its molecular determinants among Extended-spectrum beta-lactamase (ESBL)- and carbapenemase-producing (CP) Klebsiella pneumoniae (KP) and Escherichia coli (EC) isolated in Cambodia between 2016 and 2020. . EC (n=223) and KP (n=39) were tested for colistin minimum inhibitory concentration (MIC) by broth microdilution. Resistant isolates were subjected to PCR for detection of mobile colistin resistance genes (mcr) and chromosomal mutations in the two-component system (TCS). . Eighteen isolates (10 KP, 8 EC) revealed colistin resistance with a rate of 5.9% in EC and 34.8% in KP among ESBL isolates, and 1% in EC and 12.5% in KP among CP isolates. The resistance was associated with mcr variants (13/18 isolates, mcr-1, mcr-3 and mcr-8.2) and TCS mutations within EC and KP, with the first detection of mcr-8.2 in Cambodia, the discovery of new mutations potentially associated to colistin resistance in the TCS of EC (PhoP I47V, PhoQ N352K, PmrB G19R, PmrD G85R) and the co-occurrence of mcr genes and colistin resistance conferring TCS mutations in 11/18 isolates. The findings highlight the presence of colistin resistance in ESBL- and CP- Enterobacteriaceae involved in human infections in Cambodia as well as chromosomal mutations in TCS and the emergence of mcr-8.2 in EC and KP. It underscores the need for continuous surveillance, antimicrobial stewardship, and control measures to mitigate the spread of colistin resistance.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SCSokleaph Cheng
Sokleaph Cheng
SPSok Heng Pheng
Sok Heng Pheng
SHSeiha Heng
Seiha Heng
GMGuy B. Marks
Guy B. Marks
ABAnne-Laure Banuls
Anne-Laure Banuls
AKAlexandra Kerléguer
Alexandra Kerléguer
The Loopamp™ MTBC kit (TB‐LAMP) is recommended by WHO for Mycobacterium tuberculosis complex detection in low‐income countries with a still low drug‐resistant tuberculosis (TB) rate. This study is aimed at testing its feasibility in Cambodia on sputa collected from presumptive tuberculosis patients. 499 samples were tested at a smear microscopy center and 200 at a central‐level mycobacteriology laboratory. Using mycobacterial cultures as reference, TB‐LAMP results were compared with those of LED fluorescent microscopy (LED‐FM) and Xpert® MTB/RIF. At the microscopy center, TB‐LAMP sensitivity was higher than that of LED‐FM (81.5% [95% CI, 74.5‐87.6] versus 69.4% [95% CI, 62.2‐76.6]), but lower than that of the Xpert assay (95.5% [95% CI 92.3‐98.8]). At the central‐level laboratory, TB‐LAMP sensitivity (92.8% [95% CI, 87.6‐97.9]) was comparable to that of Xpert (90.7% [95% CI, 85.0‐96.5]) using stored sample. No significant difference in terms of specificity between TB‐LAMP and Xpert assays was observed in both study sites. In conclusion, our data demonstrate that TB‐LAMP could be implemented at microscopy centers in Cambodia to detect TB patients. In addition, TB‐LAMP can be a better choice to replace smear microscopy for rapid TB diagnosis of new presumptive TB patients, in settings with relative low prevalence of drug‐resistant TB and difficulties to implement Xpert assay.

24 November 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAnne-Lise Beaumont
Anne-Lise Beaumont
ALAgathe de Lauzanne
Agathe de Lauzanne
ACAlexis Criscuolo
Alexis Criscuolo
LFLaetitia Fabre
Laetitia Fabre
MRMamitina Alain Noah RABENANDRASANA
Mamitina Alain Noah RABENANDRASANA
BHBich-Tram Huynh
Bich-Tram Huynh
Early neonatal infections caused by extended-spectrum-beta-lactamase-producing Enterobacterales (ESBL-PE) are prevalent in low- and middle-income countries, posing significant treatment challenges. This study investigates ESBL-PE colonization in 499 mother-neonate pairs from Madagascar and Cambodia, with stool samples collected at delivery and from neonates during the first three days of life. Using short- and long-read sequencing, identical isolates or plasmids are detected within each pair to assess neonatal acquisition from maternal source. Associated risk factors are identified through multinomial regression. Maternal gut carriage accounts for only 16.5% of neonatal ESBL-PE acquisition, suggesting that most cases originate from other sources. Primiparity and the wet season are associated with an increased risk of acquisition from the mother, while cesarean delivery, neonatal resuscitation, and wet season are associated with acquisition from other sources. These findings challenge the paradigm that maternal carriage is the primary source of early neonatal ESBL-PE colonization, highlighting the need for further research into alternative sources to inform targeted interventions.

28 January 2019 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
LBLaurence Borand
Laurence Borand
ALAgathe de Lauzanne
Agathe de Lauzanne
NNNgoc Lan Nguyen
Ngoc Lan Nguyen
SCSokleaph Cheng
Sokleaph Cheng
TPThu Hang Pham
Thu Hang Pham
PGPediatric Asian African Network for Tuberculosis and HIV Research (PAANTHER) Study Group
Pediatric Asian African Network for Tuberculosis and HIV Research (PAANTHER) Study Group
We enrolled 427 human immunodeficiency virus–infected children (median age, 7.3 years), 59.2% severely immunodeficient, with suspected tuberculosis in Southeast Asian and African settings. Nontuberculous mycobacteria were isolated in 46 children (10.8%); 45.7% of isolates were Mycobacterium avium complex. Southeast Asian origin, age 5–9 years, and severe immunodeficiency were independently associated with nontuberculous mycobacteria isolation. NCT01331811.